Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001422849-25-000094·Allogene Therapeutics, Inc.
Schedule 13G ownership disclosure
Allogene Therapeutics Inc
Common Stock · CUSIP: 019770106
Event date: 2025-09-30
- Filing-level shares
- 0.00
- Percent of class
- 0.0%
- Capital World Investors
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001422849-25-000094
- Form type
- SCHEDULE 13G/A
- Filer
- Allogene Therapeutics, Inc.
- CIK
- CIK 1737287
- Filed
- Nov 13, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership